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The greatest burden of ill-health for adults in most societies relates to disorders of 
the cardiovascular system and to cancers [1]. These diseases are caused by lifestyle 
choices in which poor diet and relatively low levels of activity play a major role [1]. 
There is a large body of literature which shows that environmental exposures, includ-
ing nutrition, play a significant role in the etiology of the disease, but there is vari-
able susceptibility amongst individuals exposed to seemingly similar risk factors or 
environments. Cancer is a condition which results from a derangement in the cel-
lular processes which regulate cell division, terminal differentiation and apoptosis, 
with damage to the genetic material of the cell being central. Exposures which lead to 
these derangements usually precede the appearance of the clinical disease by a pro-
longed period of time, often several decades [2]. While gene mutation has a role in 
the etiology of cancer, there is increasing evidence showing that epigenetic processes 
such as DNA methylation and covalent modification to histones are also involved 
[3]. Epigenetic changes of this kind represent potential for altered gene activity, and 
hence cellular dysregulation. However, the underlying propensity may only be mani-
fest when the gene is exposed to an appropriate environmental signal with the direc-
tion of the response and nature of the cellular dysregulation a function of the specific 
epigenetic change [4, 5].
It has been known for many years that exposure of the individual to nutritional 
and other environmental challenges during critical periods of early development can 
markedly affect later size, shape, structure, function and behavior. However, Barker 
et al. [6] were the first to provide clear evidence that there might also be a direct 
link between early nutritional exposure and risk of chronic disease, building the evi-
dence that is supportive of a causal association [6, 7]. In this they have refined a new 
conceptual approach to the way in which we consider the evolution of this group of 193
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diseases based upon a new developmental model, the so called ‘fetal origins hypoth-
esis’. Based initially on ecological observations and later on retrospective cohort stud-
ies, there is now a considerable body of epidemiological and experimental data that 
supports the hypothesis. In the earlier observations, the size and shape of the baby at 
birth was shown to be related to the risk during adult life of coronary heart disease, 
hypertension, stroke, type 2 diabetes, obesity and some cancers [6]. These relations 
were shown to be graded across the usual range of birth weights seen in the popula-
tion and not a special feature of very high or very low birth weight, indicating that 
they might be a consequence of the usual range of exposure found within a popula-
tion [4, 7]. The results have been reproduced across a number of populations, and 
although there may be some debate around the details, the general principal appears 
to apply widely [4, 6, 7].
Epidemiology
Methodologically, the major advance was to be able to identify groups of adults in 
whom size at birth had been recorded with reliability and could be related on an 
individual basis to current health, risk of chronic disease, morbidity or mortality 
from specific disease conditions [8]. By identifying such populations it has been 
possible to carry out a range of elegant retrospective cohort investigations pro-
viding clear evidence that the pace and pathway of early growth is a major risk 
factor for this particular group of chronic diseases [6, 8]. The first studies were 
carried out in Hertfordshire (England), where it was shown that for both men and 
women as birth weight increased, the risk of death from coronary heart disease 
decreased. Based on observations of this kind, the ‘fetal origins hypothesis’ pro-
poses that poor nutritional exposure during early development of the fertilized 
ovum, embryo, fetus, infant or child permanently determines the structure and 
function of the body through the process of programming [7–9]. This translation 
of genotype into a defined phenotype from a very early stage of development, sets 
the basis upon which all later exposures, nutritional and those of the wider envi-
ronment, build. It defines the opportunity and limit for future structure and func-
tion [8–10]. More refined exploration of other data sets in which more detailed 
data are available for later growth during childhood and adolescence, such as the 
Helsinki Birth Cohort, provide the opportunity to identify particular pathways of 
growth that may be associated with particular disease outcomes [6]. Together these 
explorations provide a rich description of how the structural phenotype captured 
simply as measures of size, shape and body composition mark differences in the 
functional phenotype which in themselves presage variable vulnerability to a wider 
range of environmental challenges, which can ultimately lead to ill-health [6, 7]. 
These findings from these observational studies are supported by evidence derived 
from ‘natural’ experiments.194
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Experiments of Nature
The most well explored human model of a defined intervention for a specific period 
of time is given by the experience provided as a result of the Dutch famine during 
1944–1945. This was a sharply defined period of severe food shortage for a popula-
tion which previously had enjoyed reasonable nutritional health. During this period 
the food ration fell below 1,000 kcal/day and even the extra rations allowed for preg-
nant and lactating women and young children could not be provided [11, 12]. The 
change in food availability had a disastrous effect on the population, but although fer-
tility decreased women continued to become pregnant and deliver babies and health 
records continued to be kept. It has been possible to time the relative exposure of 
the famine in relation to the time of conception and the progress of the pregnancies. 
Women who were exposed early in pregnancy, around the time of embryonic growth 
and the elaboration of the early fetal form had babies which were of relatively good 
size, but later in life suffered the more extensive and severe manifestations of ill health 
for a range of systems. Those exposed during later pregnancy, at a time when many of 
the structures and functions of the fetus have been established, but when the weight 
gained is greatest, had babies who were most obviously affected by having a lower 
birth weight. They still carried an increased risk for later ill health, but this was less 
marked than those exposed during the earlier stages of development. Those fetuses 
exposed to famine during late gestation were more likely to demonstrate impaired 
glucose tolerance during adult life. Those exposed in mid-gestation had an increased 
likelihood of impaired glucose tolerance, but also were more likely to display microal-
buminuria indicative of altered renal function or obstructive airways disease indica-
tive of altered respiratory function. Exposure early in gestation was associated with 
later glucose intolerance, an atherogenic lipid profile, altered blood coagulation, obe-
sity, stress sensitivity, coronary heart disease and breast cancer [11, 12].
These observations demonstrate an effect on a wide range of functions and sys-
tems, variability in outcome in relation to the timing of the exposure indicative of 
special tissue vulnerability at sensitive periods of development, disjunction between 
the specific functional effects and the size of the baby at birth. In addition to the spe-
cific time-related effects from one tissue or system to another, there is also evidence 
that for those conceived during the famine there was an increased risk of schizophre-
nia, anti-social personality disorder, and congenital neural defects, demonstrating a 
wide range of effects on the central nervous system [11, 12]. The vulnerability implied 
by increased sensitivity and stress responsiveness increases the potential susceptibility 
to all stressors and associated metabolic consequences. Importantly, stressors interact 
with and impact upon nutritional state and wellbeing through a range of effects that 
include altered appetite, modification in the delivery of nutrients to tissues, altered 
tissue demands for nutrients and increased nutrient losses. The effects found on liver 
function (coagulation changes and lipid profiles) and renal health (micralbuminuria) 
imply the likelihood of altered responsiveness to potential or actual environmental 195
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toxins, including carcinogens, altered excretion, modified inter-organ co-operativity 
and integration of function [11, 12]. Not all of the effects should be construed as 
being necessarily negative. Those women who were exposed to the famine during 
their own fetal life later showed increased reproductive success [13]. Importantly it 
has been shown the effects can be passed on to the third generation, arguing strongly 
for non-genomic transmission of information or memory [14].
Thus, birth size provides some useful information, but has to be seen as a relatively 
crude indicator of the intrauterine nutritional exposure and experience, patterns of 
exposure during fetal life set structure and functionality that have long-term impact 
on the capacity of individual tissues to function and their integration as components 
of a whole body system, growth and development after birth may be modulated by 
experience before birth, but how current environmental exposure builds on that 
experience is itself of importance for later health or disease risk.
Cancer Risk and Early Life
The fundamental lesion in cancer is damage to DNA, which can be brought about 
by a range of physical, chemical or microbiological factors. Because the cell usually 
has mechanisms to protect itself, sustained damage to DNA must take place against a 
background of a cellular capability that is inadequate to cope by protecting or effec-
tively repairing the damaged DNA. The capability of the cell to achieve effective 
prevention or repair depends upon the cellular microenvironment, in particular the 
nutrient microenvironment of the cell. This microenvironment reflects the overall 
nutritional wellbeing of the individual, a balance between nutrient intake and the 
specific nutrient demands for usual activity and coping with the rigors imposed by 
the wider external environment [4]. Cells that contain critically damaged DNA but 
do not undergo apoptosis are potentially neoplastic. Dysregulation of the life cycle of 
individual cells is, therefore a fundamental feature of cancer causation. This is in part 
determined by the immediate nutrient environment, but also by the nutrient environ-
ment experienced during very early development [4, 5].
The studies from the women who experienced the Dutch hunger winter during 
early life showed that there was a 5 times increase in risk of developing cancer of the 
breast in women exposed to famine while in utero [15]. Birth size has been related 
to increased risk of breast cancer in a number of studies and, in general, larger size 
at birth is associated with an increased risk of cancer of the breast [2, 5]. In 2007 the 
World Cancer Research Fund and American Institute of Cancer Research [2] pro-
duced the most comprehensive review of any aspect of the medical literature ever 
conducted. This global effort by some of the world’s leading nutrition and cancer sci-
entists identified major factors related to the foods eaten, nutritional status achieved 
and physical activity undertaken as causal factors for major cancers. This analysis was 
comprehensive, detailed and rigorous, using sound, validated methods and hence its 196
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conclusions are the most authoritative statement there is currently on the causes of 
cancer. It is estimated that on average at least 30% of cancers could be prevented with 
appropriate modifications to diet and lifestyle, and in some situations as much as 70% 
[16]. There is convincing evidence that abdominal fatness causes colorectal cancer, 
and probably causes cancer of the pancreas and endometrium and pre-menopausal 
breast cancer. There is also convincing evidence that achieved height ‘causes’ colorec-
tal and postmenopausal breast cancer, and probably ‘causes’ cancer of the pancreas 
and ovary and premenopausal breast cancer. This very strong relationship between 
achieved height itself and specific cancer cannot be a direct effect of height on the risk 
of cancer, but must be a reflection that the complex of factors that contribute to the 
achievement of height, must also relate strongly, and probably directly to the factors 
which increase the risk of cancer. Other aspects of development of the bony skel-
eton have been related to cancer in women in the Helsinki Birth Cohort, where 300 
women were diagnosed with breast cancer [6]. Growth of bony skeleton is important 
for reproductive health in many ways, but most critically during child birth where 
small pelvic bones increase the risk of obstructed labor. Small pelvic bones are often a 
persistent consequence of poor nutrition during infancy and childhood. In Helsinki, 
the dimensions of the mothers’ bony pelvis were measured routinely in order to assess 
the likelihood of an obstructed labor. A higher risk of either breast cancer or ovar-
ian cancer in the daughter was associated with the shape and pattern of the mother’s 
pelvis, itself a marker of the mother’s sex hormone status around the time her repro-
ductive capability was being established [17, 18]. The stem cells for the breast form at 
around 6 weeks after conception and the authors postulated that higher concentra-
tions of sex hormones in the mother around this time gave rise to genetic instability 
in the differentiating putative breast cells in their daughters [17]. Further, they found 
that broader hips in the mother were predictive of ovarian cancer in their daughters, 
leading to the suggestion that ovarian cancer may be initiated by exposure of the fetal 
ovary to maternal sex hormones [18].
Growth and Development
Growth is a complex process that takes place in both space and time. Early expo-
sures can have lasting effects, both on structure and on function. The most obvi-
ous example of this is when a noxious exposure acts during a sensitive period of the 
development of a tissue or organ, impairing the development and leading to lifelong 
alterations of structure, for example with teratogens such as thalidomide or hypervi-
taminosis A [19, 20]. However, a limitation or lack of a specific nutrient can have an 
equally damaging structural effect, such as hypovitaminosis A, or poor folate status 
and neural tube defects [21, 22]. These obvious structural changes at the level of the 
whole body are extreme forms of less dramatic damage which can be inflicted at the 
cellular or subcellular levels.197
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An understanding of how early nutritional exposure enables normal growth and 
body proportions, measured indirectly as achieved height and weight, is an impera-
tive if the relationships identified in epidemiological studies of populations are to be 
interpreted [7, 9, 10, 23, 24]. Growth is a structured process which includes increases 
in length and mass, changes in body composition and relative proportions and matu-
ration of function. The elaboration of the processes that enable structure and func-
tion at every stage of growth and development result from a complex interaction 
amongst genetic endowment and the hormonal milieu with the availability of energy 
and nutrients to fuel and enable cellular elaboration [25]. In an article in the Lancet 
in 1970, Elsie Widdowson used the term ‘harmony of growth’ to capture the pace, 
proportions and partitioning of nutrients that are fundamental for the achievement 
of normal growth, appropriate body proportions and effective maturation of function 
[26]. Thus, growth and development are tightly organized and regulated processes 
with complex and subtle changes taking place in space and time, with each successive 
change being dependent upon and determined by having achieved the early stages 
with a measure of success. Any significant constraint at any particular stage of devel-
opment may lead to alteration of structure and function, which may be difficult or 
impossible to repair or make good at later times. Any tissue or organ is particularly 
vulnerable at the time of rapid cellular replication, leading to sensitive periods during 
development which differ in their critical timing from tissue to tissue or from func-
tion to function. Throughout there is a close interdependent relationship between 
structure and function, thereby capturing a memory of differences in earlier expo-
sure to an altered cellular or tissue, hormonal or nutritional milieu. For any complex 
organism, this variability in structure and function can obtain at any or every level of 
organization, extending from the molecular and subcellular, through the organization 
and regulation of cells, tissues and organs, up to whole body integration of responses 
to wider environmental challenge. Size at any age is a relatively crude summary state-
ment of the extent to which the availability of energy and pattern of nutrients matches 
that required for that stage of development, and size at birth is a very crude summary 
of the nutrients that have been available to the fetus.
The size of newborn babies and their growth during infancy and childhood have 
changed over time [27, 28]. During approximately the last 100–150 years, children 
have been getting larger and growing to maturity more rapidly, known as the secu-
lar trend in growth with progressively greater final adult height in many developed 
countries. Thus, within the same population there has been a progressive increase in 
attained adult height for both males and females, a reflection of increased height at 
5–7 years of age of 1–2 cm every 10 years [27, 28]. This has been associated with a 
decrease in the age of menarche from around 16 to around 13 years of age in the 100 
years from 1860 [27]. For a number of countries in western Europe this attained adult 
height appears to have achieved a plateau of around 1.8 m, for example in Denmark, 
Sweden, Norway and the Netherlands. It has been suggested that the plateau is 
achieved around 18 years following post-neonatal mortality falling to around 4/1,000 198
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deliveries [23, 24]. In many senses this increase in height is indicative of improvement 
in public health and much of the increase has been attributed to factors that contrib-
ute to improved nutrition from a very early age. Importantly if achieved height is a 
risk factor for some cancers and there has been a secular trend in height over many 
years, what are the common factors that underlie this important relationship?
Size and Body Composition at Birth
The new growth standards developed by WHO show how infants and children 
should grow when provided with the opportunity for a healthy environment [29]. 
Across the globe the pattern of growth of children from a wide range of backgrounds 
is similar. However, even within this similarity for all populations there is variability 
within the normal range. The suggestion posed by the ‘fetal origins hypothesis’ is that 
even within this observed ‘normal’ range of variability there is differential risk of later 
chronic disease.
There has been the general observation that infants who are smaller at birth tend 
to have a different body composition to those who are heavier, most notably that they 
are relatively more adipose. An extreme example of this difference has been noted 
in populations where size at birth is very low, for example in India. Yajnick et al. 
[30] have described the phenotype of the Indian baby as being fat/thin, a pattern that 
is carried through to adulthood and marks the phenotype which is closely associ-
ated with the cardio-metabolic syndrome. Although the baby may be small at birth 
the relative deficit of different body compartments is not equal. There are substantial 
deficits in length and lean tissue, but relative preservation of adipose tissue, especially 
centrally placed adipose. This population has substantially increased risk of type 2 
diabetes, associated with relative adiposity throughout life, which may be directly 
associated with dietary limitations of vitamin B12 [31]. One important question is 
whether this is a peculiarly Indian phenotype and problem, or simply an extreme 
example of a more common phenotypic difference in size and shape, and also for 
wider aspects of metabolic function.
Kensara et al. [32, 33] compared the extent to which early life variability in size 
relates to differences in size, shape and whole body function later in life using the 
Hertfordshire cohort and comparing individuals from the lowest and highest fifths of 
birth size within the ‘normal’ range. These men were studied when they were around 
70 years old. At this age the percentage body fat was about 5% greater for those of 
lower birth weight compared with those of higher birth weight. This meant that for 
the same weight or BMI at 70 years of age, those of lower birth weight had reduced 
lean mass, but greater fat mass, especially greater central fat [32]. Resting metabolic 
rate (RMR) was measured as a summary statement of metabolic activity and 38% of 
the variability in RMR could be explained by variation in current size (height and 
weight) and size at birth. Those in the lower birth weight category had lower resting 199
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expenditure, 32% of which was explained by differences in birth size, indicative of 
a reduced metabolic demand, a reduced metabolic capacity, and altered cellular 
environment. Size at birth uniquely explained 17% of the variability, more than cur-
rent size which uniquely explained 6% of the variability, with 15% of the variability 
explained on a shared basis by size at birth and current height and weight [33]. The 
compositional changes meant that for any given BMI the men of lower birth weight 
had 5% more fat [32]. Therefore, the differences in body composition identified for 
the Indian baby with the fat/thin phenotype may represent a more general differ-
ence in phenotype associated with differences in size at birth, which in itself marks 
important variability in overall and specific metabolic function and efficiency [34]. 
Although differences in genotype may explain a part of this variability, the observa-
tion that the WHO growth standards apply globally [29] indicate that there are major 
environmental factors that impact on the variability, which include nutrition factors, 
either directly or indirectly.
Developmental Plasticity
The epidemiological and metabolic studies carried out in humans argue strongly that 
nutrient exposure from the earliest stages of life can exert an impact on functional 
capability at all later ages, indicating that a single genotype can give rise to a range 
of different phenotypes. This process, characterized as developmental plasticity, is a 
widespread biological phenomenon which is considered to enable survival in range 
of environments, and the ability to cope with the range of stresses or stressors expe-
rienced from one situation to another [35]. This variable phenotype may promote 
the ability to cope in the short term, but carries with it potential vulnerability in the 
longer term especially if the later environment exposes phenotypic susceptibility. 
Greater achieved height and central adiposity may confer advantages under some cir-
cumstances, but they are not necessarily an unalloyed benefit. It is very difficult to 
explore these relationships mechanistically in humans, given the long time between 
the exposure and the outcome, and animal models provide a valuable opportunity to 
determine possible mechanisms in some detail.
Animal Models
There are a wide range of studies on the reproductive performance in animals – con-
ducted for the purpose of enhancing animal husbandry – which have explored the 
effects of general or specific nutritional interventions before or during pregnancy, 
during lactation and during the later life of the offspring. These generally have an 
interest in relatively short-term outcomes, determined by market considerations. It 
is clear that more extreme dietary manipulations lead to adverse outcomes in the 200
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short and longer term, with the specific consequence being determined by the timing, 
severity and duration of the insult [7, 19–22]. An important observation which arises 
from the epidemiological studies is that for chronic non-communicable disease the 
variability in risk is seen as a graded effect within the usual variability of birth size 
and growth within the population. For the diet or nutritional exposure to operate 
as an important factor in promoting or enabling the altered risk in outcome would 
require that the effects of importance should be demonstrable across the range of 
intakes usually seen and considered to be compatible with health within the popula-
tion. Further, if the impact is cumulative during life it might be explained simply by 
sensitive periods during development leading to differences in structure and function 
which constrain the maximal capability of one or other function, or limit the abil-
ity to regulate and integrate [7, 25]. However the observation that these effects can 
be communicated between generations, and by embryo transfer, requires acquired 
genetic mechanisms of retained memory, considered most likely to be through epige-
netic processes such as DNA methylation and covalent modification of histones [5]. 
This potentially implicates those processes through which 1-carbon moieties such as 
methyl groups are made available to metabolism and the mechanisms through which 
methylation of the promoter region of specific regulatory genes is enhanced or con-
strained from one situation to another [5].
The induction of changes to the phenotype of the offspring, in response to the 
prenatal environment, that persists throughout the lifespan implies stable changes to 
gene transcription resulting in altered activities of metabolic pathways and the set 
point homeostatic control processes and in differences in the structure of tissues. One 
important consideration in understanding the mechanism responsible for phenotype 
induction is the interaction between any process resulting in different phenotypes, 
environmental cues and gene polymorphisms, in particular those located in gene 
promoters. Studies on gene expression demonstrate stable effects on transcription [5]. 
Importantly, some of the genes which showed altered expression following prenatal 
undernutrition are transcription factors which affect multiple pathways in develop-
ment and nutrient homeostasis: for example PPARα and the glucocorticoid receptor 
(GR) [36]. Modified regulation of expression of a few key transcription factors may 
alter the activities of a large number of metabolic and developmental pathways. The 
methylation of CpG dinucleotides which are clustered at the 5 promoter regions of 
genes, confers stable silencing of transcription. Methylation patterns are largely estab-
lished during embryogenesis or in early postnatal life [37]. DNA methylation also 
plays a key role in cell differentiation by silencing the expression of specific genes dur-
ing development and differentiation of individual tissues, and thus the timing of gene 
methylation is tissue and gene-specific [38, 39]. Covalent modifications of histones 
influence chromatin structure and hence the ability of transcriptional machinery to 
gain access to DNA. DNA methylation can induce transcriptional silencing by block-
ing the binding of transcription factors and/or through promoting the binding of the 
methyl CpG binding protein (MeCP)-2. The latter binds to methylated cytosines and, 201
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in turn, recruits histone-modifying complexes composed of deacetylases and histone 
methyl transferases to the DNA, resulting in a closed chromatin structure and tran-
scriptional silencing [40, 41].
Epigenetic regulation of gene promoters is established during development and is 
responsible for patterns of transcriptional expression and silencing in adults, pertur-
bations to this process represent a candidate molecular mechanism for induction of 
persistent alterations in phenotype by the environment early in life. Perturbations as 
diverse as lack of maternal grooming, uterine artery ligation or embryo culture have 
been shown to lead to epigenetic modulation of transcription, structural and func-
tional effects in the short and long term [5, 42–45].
Varying the maternal intake of nutrients involved in 1-carbon metabolism across 
a wide range can induce graded changes in DNA methylation and gene expression 
in the offspring, which persist into adulthood [45]. However, for this mechanism to 
operate in the induction of phenotypes associated with the ‘fetal origins hypothesis’ 
would require that it can operate within the range of dietary intakes typical for a pop-
ulation. Feeding a diet which is adequate but restricted in protein to pregnant rats is 
a well established model of phenotype induction. This is because feeding pregnant 
dams graded amounts of protein across a range of intakes not associated with any 
obvious pathology leads to graded increases in blood pressure in the offspring [46]. 
This modest change to maternal macronutrient intake during pregnancy induced 
hypomethylation of the PPARα and GR promoter and increased expression of PPARα 
and GR in the liver of the offspring. There was also an increase in the expression of 
PPARα and GR target genes such acyl-CoA oxidase and phosphoenolpyruvate car-
boxykinase, respectively, supporting the suggestion that altered epigenetic regulation 
of transcription factors modifies that activities of important metabolic pathways [36, 
47]. Sequence analysis of the PPARα promoter showed that the methylation status of 
only a few CpG dinucleotides was altered by the reduced protein diet during preg-
nancy [48]. This suggests that the process of induced epigenetic change is targeted 
and that the resulting change in transcription may reflect changes in the interaction 
of the gene with relatively few transcription factors, thus inducing specific changes 
in the regulation of gene function and hence response to environmental differences. 
Methylation of the PPARα and GR promoters was also reduced in the heart of animals 
whose mothers had been exposed to a reduced protein diet during pregnancy [5]. 
Further, the PPARα promoter was hypomethylated in the whole umbilical cord off-
spring of rats fed a reduced protein diet during pregnancy [5], suggesting that hypom-
ethylation of PPARα and GR promoters had already been established very early in 
pregnancy, before cell lineages had become definitively established. Hypomethylation 
of the GR promoter was associated with an increase in histone modifications which 
facilitate transcription while those that suppress gene expression were reduced or 
unchanged [47].
Induction of the altered phenotype (hypertension and endothelial function) in 
the offspring of rats fed the reduced protein diet during pregnancy was prevented 202
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by supplementation of this diet with glycine or folic acid [49–51]. Hypomethylation 
of the hepatic PPARα and GR promoters was also prevented by the addition of 5 
times more folic acid than contained in the reduced protein diet [36]. Thus, 1-car-
bon metabolism plays a central role in the induction of an altered phenotype. In this 
model there is an important interaction between the metabolism of macronutrients 
and micronutrients, and further that these interactions operate through differential 
methylation of the promoter region of regulatory genes through seemingly epigenetic 
mechanisms. The regulatory genes themselves play a central role in metabolic inte-
gration in terms of responsiveness to stress (GR), and macronutrient partitioning and 
central fat deposition (PPARα). Feeding the reduced protein diet during pregnancy in 
the F0-generation results in elevated blood pressure, endothelial dysfunction, insulin 
resistance and adverse glucose homeostasis in the F1, F2 and even the F3 generations, 
despite no further unusual dietary exposure for subsequent generations [52–55]. This 
implies that transmission of a phenotype induced in the F1 generation to the F2 gen-
eration and further into the F3 generation may involve preservation of levels of DNA 
methylation of specific genes. As the female line appears sufficient for transmission 
of this epigenetic information between generations the level of methylation of the 
PPARα and GR promoters in gametes must be similar to that of somatic cells.
The de novo methylation of CpG dinucleotides is catalyzed by DNA methyltrans-
ferase (Dnmt) 3a and 3b. The pattern of methylation is maintained through mitosis 
by gene-specific methylation of hemimethylated DNA by Dnmt1 [37]. Changes in the 
activity of Dnmt as a result of altered 1-carbon metabolism represent one candidate 
mechanism for transmission of information regarding maternal 1-carbon metabo-
lism status to the fetus for induction of modified epigenetic regulation of transcrip-
tion and thus modified phenotype. Feeding the reduced protein diet to rats during 
pregnancy induced a reduction in Dnmt1 expression and in the binding of Dnmt1 
at the GR promoter. [47]. However, the expression of Dnmt3a, Dnmt3b and methyl 
binding domain-2, and the binding of Dnmt3a at the GR promoter were unaltered 
[47]. This suggests that hypomethylation of the GR promoter in the liver of the off-
spring and probably other genes including PPARα, is induced by the maternal diet as 
a result of a lower capacity to maintain patterns of cytosine methylation during mito-
sis. Modulation of Dnmt1 expression by differences in 1-carbon metabolism provide 
a link between maternal diet and epigenetic regulation of gene expression in the fetus. 
This is supported by the finding that lower Dnmt1 expression induced by the reduced 
protein diet during pregnancy was prevented by increasing the folic acid content of 
the diet. [47] and is consistent with the a central role for Dnmt1 in the induction of an 
altered phenotype [49, 50].
We suggest 2 possible mechanisms by which feeding a reduced protein diet during 
pregnancy may alter 1-carbon metabolism. Firstly, it is possible that a decreased avail-
ability of glycine leads to an altered flux of methyl groups between different metabolic 
fates and a constraint on the remethylation of homocysteine to methionine [56, 57]. 
Second, increased maternal corticosteroid levels [58], possibly a result of the stress 203
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induced by constrained nutrient availability, may reduce folic acid availability [59]. 
The latter could explain how maternal corticosteroid blockade prevents the induction 
of hypertension in the offspring of mothers who had reduced protein diets during 
pregnancy [60], as well as prevention of altered phenotype by folic acid administra-
tion [36, 50].
Based upon current data, we have suggested a mechanism for the induction of an 
altered phenotype in the offspring as a consequence of nutrient constraint during 
pregnancy in which promoter methylation is lost in a gene-specific manner during 
mitosis due to decreased Dnmt1 expression and activity [5, 36, 61]. This is accompa-
nied by reduced binding of the MeCP2-histone deacetylase-histone methyltransferase 
complex leading to persistence of histone modifications that permit transcription.
Epigenetics and Cancer
A change in the epigenetic regulation of genes has been implicated as a causal 
mechanism in specific cancers including lung, prostate, breast [62], colon [63] and 
hemopoietic cancers [64]. Specifically, increased cancer risk is associated with global 
hypomethylation of the genome with concurrent hypermethylation or hypomethyla-
tion of the promoter of specific genes. The mechanism by which global hypomethy-
lation is induced is unclear, but may reflect the global decline in DNA methylation 
associated with increasing age [62]. The age-related decline in global hypomethylation 
is related to a reduction in Dnmt1 activity [65] which, in turn, may induce expression 
of oncogenes such as c-Myc and c-N-ras. [65]. Thus, it appears that modulation of 
Dnmt1 activity is a key regulatory step in both fetal programming and in the induc-
tion of tumorigenesis This may be accompanied by de novo methylation of tumor 
suppressor genes [66] by increased Dnmt3a activity, leading to aberrant activation of 
genes involved in cell proliferation and cell differentiation [67]. Together these changes 
represent a shift in the regulation of gene control which, in turn, may predispose the 
genome to further changes in methylation, which result ultimately in neoplasia.
Conclusion
The observation that nutrition in early life can induce both hypomethylation and 
hypermethylation of specific CpG dinucleotides suggests a mechanism for induc-
tion of different disease endpoints (e.g. metabolic disease of cancer) by variation in 
the same environmental exposure, which is marked by differences in the direction of 
association between birth weight and disease risk. One particular example of the role 
of epigenetics in modulating gene activity by shifting the balance between agonist and 
suppressor proteins is the induction tumorigenesis by activation of telomerase in dif-
ferentiated cells. Telomerase activity is down-regulated in most cells during terminal 204
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differentiation in embryogenesis as a result of methylation of the CpG promoter 
region. It has been proposed that activation of telomerase in preneoplastic cells is 
due to a shift in the regulation between the activator c-Myc and the suppressor WT1, 
by changes in the methylation status of specific CpG within the binding domains of 
these transcription factors in the promoter of the catalytic sub-unit which confers RT 
activity (hTERT) [68]. One consequence of hTERT activation is to increase Dnmt1 
activity [69], which leads to copying of aberrant patterns of cytosine methylation. 
This suggests a synergistic role for hTERT and Dnmt1 in controlling cell proliferation 
and the methylation status of the genome.
The addition of supplemental folic acid to the reduced protein diet provided during 
pregnancy reversed many of the effects of the low protein diet on blood pressure and 
vascular reactivity as well as on the methylation of the promoter region for PPARα and 
GR and their relative expression in the offspring. By contrast when the control protein 
diet was supplemented with folic acid the effects on the offspring were very different, 
with an increase in blood pressure and increases in the concentration of triacylglyc-
erol and non-esterified fatty acids in the blood [70]. If the addition of supplemental 
folic acid to the reduced protein diet provided during pregnancy reversed many of the 
phenotypic and epigenetic effects of the low protein diet in the offspring would a simi-
lar effect be seen if the supplemental folic acid were provided to the offspring post-
natally? Supplementation with folic acid postnatally induced increased weight gain, 
lower plasma β-hydroxybutyrate concentration and increased hepatic and plasma 
triacylglycerol concentration compared with offspring not given supplemental folic 
acid. In the liver of folic acid supplemented offspring there was an increased methyla-
tion of the promoter region for PPARα and the GR, and a decrease in the methyla-
tion of the promoter region for the insulin receptor, with reciprocal changes in mRNA 
expression. Hence increased intakes of supplemental folic acid intake during the juve-
nile period did not simply reverse the phenotype induced by the maternal diet, but 
produced distinct changes in both the phenotype and the epigenotype. This indicates 
that the effect of the increased intake of folic acid is contingent on the timing of the 
supplementation relative to the developmental stage of the organism and the overall 
nutrient pattern within the diet. Importantly, whereas during pregnancy the effect of 
the supplemental folic acid is buffered by maternal metabolism, the juvenile offspring 
were exposed directly to folic acid provided in the diet [71]. Bidirectional responses in 
relation to the previous nutritional exposure have also been shown for other systems, 
for example in rats the expression of 11β-hydroxysteroid dehydrogenase-2 in response 
to leptin administration from day 3 to 10 of life was increased in the offspring of well 
nourished mothers, but decreased in the offspring of undernourished mothers: by 
contrast leptin suppressed expression of PPARα in maternally well nourished off-
spring and enhanced expression in maternally undernourished offspring [72].
The observational evidence from epidemiological studies is substantial. Not sur-
prisingly, not all of the evidence fits in a simple way, but there is a substantial weight 
of evidence that argues that patterns of growth and development during fetal life, 205
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infancy and childhood relate strongly to the risk of non-communicable disease dur-
ing later adult life. The experience drawn from the Dutch winter famine, where there 
was limited exposure to a very low food intake for a defined period of time, is sup-
portive. Moreover it provides evidence that the timing as well as the severity of the 
exposure lead to differences in the phenotypic outcome in terms of markers of risk 
for later ill-health as well as specific disease patterns. Taken together, the evidence 
argues that the variability in risk cannot be explained simply on the basis of genetic 
or genomic variability, but appears to be a complex interaction of nutrient exposure 
and the hormonal milieu at the critical time when tissues and systems are especially 
sensitive to environmental perturbations, which modifies the opportunity for genetic 
expression, most likely through epigenetic mechanisms. Animal studies show that 
modest manipulations of the maternal diet during pregnancy can lead to epigenetic 
changes in the promoter region of critical regulatory genes, which are carried through 
generations. These epigenetic changes lead directly to differential expression of the 
genes and a shift in the set point and responsiveness of regulatory systems. It appears 
that it is this shift that alters responsiveness of the organism to wider environmental 
or nutritional perturbations, lowering the threshold for adverse effects and increasing 
susceptibility to abnormal function. The evidence suggests that aspects of the regu-
lation and control of 1-carbon metabolism are of particular importance in setting 
the extent of epigenetic modification and, our understanding of the critical factors 
that determine and control these interactions needs greater refinement. At each age 
the response to current nutritional exposure appears to be modified to an extent by 
previous nutritional experience. It appears that metabolic plasticity is directionally 
dependent on earlier nutritional status and we still do not know what might underlie 
this response. Population studies show that whereas higher birth weight within an 
acceptable range is related to better long-term outcome for many of the health issues 
of concern, such as cardiovascular disease and type 2 diabetes, the opposite is true for 
cancers such as those of the breast and prostate. If the objective is to move to inter-
ventions that will protect the population from ill-health there is an important and 
urgent need to understand the basis of these different relationships to ensure that the 
public health implications can be appreciated.
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